Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
OrthoPediatrics | KIDS | 24. dec 2024 | 22.57 | -0.20 |
Oruka Therapeutics | ORKA | 24. dec 2024 | 21.13 | +0.62 |
OS Therapies | OSTX | 24. dec 2024 | 3.83 | +1.32 |
Oscar Health A | OSCR | 24. dec 2024 | 13.40 | -1.47 |
Oshkosh | OSK | 24. dec 2024 | 94.72 | +0.03 |
OSI Systems | OSIS | 24. dec 2024 | 176.13 | +0.86 |
Osisko Development | ODV | 24. dec 2024 | 1.78 | +1.71 |
Osisko Gold Royalties | OR | 24. dec 2024 | 18.33 | +0.49 |
Ostin Technology Group | OST | 24. dec 2024 | 0.16 | -13.57 |
Otis Worldwide | OTIS | 24. dec 2024 | 94.00 | +0.52 |
Otter Tail | OTTR | 24. dec 2024 | 75.12 | +0.79 |
Ouster | OUST | 24. dec 2024 | 12.81 | +4.91 |
Outbrain | OB | 24. dec 2024 | 7.60 | +2.98 |
Outfront Media | OUT | 24. dec 2024 | 18.05 | -0.44 |
Outlook Therapeutics | OTLK | 24. dec 2024 | 1.47 | +3.52 |
Outset Medical | OM | 24. dec 2024 | 1.13 | -4.24 |
Ovid Therapeutics | OVID | 24. dec 2024 | 0.97 | +1.75 |
Ovintiv | OVV | 24. dec 2024 | 38.76 | +1.65 |
Owens & Minor | OMI | 24. dec 2024 | 12.72 | +1.27 |
Owens Corning | OC | 24. dec 2024 | 171.09 | +0.11 |
Owlet A | OWLT | 24. dec 2024 | 4.62 | -0.43 |
Oxbridge Re | OXBR | 24. dec 2024 | 3.95 | +3.45 |
Oxford Industries | OXM | 24. dec 2024 | 79.78 | -1.32 |
Oxford Lane Capital | OXLC | 24. dec 2024 | 5.16 | +0.98 |
Oxford Lane Capital 2027 Pref | OXLCP | 24. dec 2024 | 24.00 | +0.38 |
Oxford Square Capital | OXSQ | 24. dec 2024 | 2.50 | +0.81 |
P10 | PX | 24. dec 2024 | 12.82 | +0.79 |
P3 Health Partners A | PIII | 24. dec 2024 | 0.18 | -5.62 |
PACCAR | PCAR | 24. dec 2024 | 105.18 | +0.46 |
Pacific Biosciences of California | PACB | 24. dec 2024 | 1.95 | +1.04 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.